Entourage Health Corp.

CVE: ENTG


Canadian symbol: ENTG.V
US symbol: ETRGF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 6.17M
Enterprise Value 145.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.15
Price/Book (mrq)N/A
Enterprise Value/Revenue 3.57
Enterprise Value/EBITDA -1.43

Trading Information

Stock Price History

Beta (5Y Monthly) 1.74
52-Week Change 3-33.33%
S&P500 52-Week Change 316.57%
52 Week High 30.0500
52 Week Low 30.0150
50-Day Moving Average 30.0180
200-Day Moving Average 30.0225

Share Statistics

Avg Vol (3 month) 390.03k
Avg Vol (10 day) 391.8k
Shares Outstanding 5308.39M
Implied Shares Outstanding 6308.39M
Float 8306.66M
% Held by Insiders 120.33%
% Held by Institutions 10.00%
Shares Short (Sept 14, 2023) 41.35k
Short Ratio (Sept 14, 2023) 40.01
Short % of Float (Sept 14, 2023) 4N/A
Short % of Shares Outstanding (Sept 14, 2023) 40.00%
Shares Short (prior month Aug 14, 2023) 414.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-108.29%

Management Effectiveness

Return on Assets (ttm)-32.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)40.79M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)5.00%
Gross Profit (ttm)N/A
EBITDA -41.75M
Net Income Avi to Common (ttm)-124.44M
Diluted EPS (ttm)-0.4000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.44M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)148.95M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.21
Book Value Per Share (mrq)-0.39

Cash Flow Statement

Operating Cash Flow (ttm)-25.9M
Levered Free Cash Flow (ttm)-20.36M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
ENTG.V
Entourage Health
2 weeks ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
2 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
5 months ago
ENTG.V
Entourage Health
5 months ago
ENTG.V
Entourage Health
5 months ago
ENTG.V
Entourage Health
5 months ago
ENTG.V
Entourage Health
6 months ago
ENTG.V
Entourage Health
6 months ago
ENTG.V
Entourage Health
6 months ago
ENTG.V
Entourage Health
6 months ago
ENTG.V
Entourage Health
7 months ago
ENTG.V
Entourage Health
8 months ago
ENTG.V
Entourage Health
10 months ago
ENTG.V
Entourage Health
10 months ago
ENTG.V
Entourage Health
11 months ago
ENTG.V
Entourage Health
11 months ago
ENTG.V
Entourage Health
11 months ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago
ENTG.V
Entourage Health
4 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/AN/AN/AN/A
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts1221
Avg. Estimate12.19M5.86M29.43M42.27M
Low Estimate13.6M8.3M31.69M43.41M
High Estimate13.6M8.6M32.6M43.41M
Year Ago Sales6.65M7.98M20.82M29.43M
Sales Growth (year/est)83.10%-26.60%41.40%43.60%
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate0000
7 Days Ago-0.040-0.14-0.17
30 Days Ago-0.040-0.14-0.17
60 Days Ago-0.040-0.14-0.17
90 Days Ago-0.040-0.14-0.17
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesENTG.VIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
20.33%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
1Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Tucker Asset Management LLC 354Jun 29, 20230.00%7
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Entourage Health Corp.


Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis 

Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis 

Entourage addresses market demand for affordable premium cannabis with new brand, Dime Bag® The Company announces Syndicate, a collective of exclusive cultivars from micro-cultivators  TORONTO, Aug. 24, 2023 -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage"), a leading Canadian producer and distributor of accl... Read More...
Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30

Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30

TORONTO, Aug. 09, 2023 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2023 financial statements and management’s discussion and analysis after market on Tuesday, August 29,... Read More...
Entourage Health Announces Results of 2023 Annual General Meeting of Shareholders

Entourage Health Announces Results of 2023 Annual General Meeting of Shareholders

TORONTO, June 14, 2023 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held v... Read More...
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results

Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results

<!-- Name:DistributionId Value:8813150 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 --> <!-- Name:CustomerId Value:1096101 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:5566b442-9002-41ac-b027-9ec825c92dfd --> TORONTO, April... Read More...
Entourage Health's Color Cannabis Receives 2022 ADCANN Award for Canadian Marketing Campaign of the Year

Entourage Health’s Color Cannabis Receives 2022 ADCANN Award for Canadian Marketing Campaign of the Year

Consumer-facing cannabis awards recognize the brands' 'Just Add Color' marketing campaign as the best in 2022Company’s Chief People Officer resigning effective February 1, 2023 TORONTO, Jan. 25, 2023 -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of awar... Read More...
Entourage Health Updates Senior Secured Amended and Restated Credit Facility

Entourage Health Updates Senior Secured Amended and Restated Credit Facility

TORONTO, Jan. 03, 2023 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an amendment (the “Amendment”) to its senior secured amended and restated credit facility entered into on October 28, 202... Read More...
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue

Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue

Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical offeringsEntourage to transition away from cultivation as it phases out growing facilities, generating annualized cost savings of over $10 million and anticipated margin accretionSteadily improves capi... Read More...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $30 Million in Non-Dilutive Funding Availability

Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $30 Million in Non-Dilutive Funding Availability

TORONTO, Oct. 31, 2022 -- Entourage Health Corp. ( (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pen... Read More...
Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products for its Largest Retail Product Call to Date

Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products for its Largest Retail Product Call to Date

Debuts: ‘Color Calendar’, a unique take on an adult-use Advent calendar featuring 24 pre-rolls; ‘Saturday Cranberry Sauce’ vape; ‘Color Live Resin Soft Chews’ and 'Color Infused Pre-Rolls'The Boston Beer Company’s cannabis-infused ‘TeaPot’ beverages arrive in Ontario, early Nov. TORONTO, Oct. 26, 2022 -- Entourage Health Corp. (TSX-V:ENT... Read More...
Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers

Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers

Syndicate marketplace showcases a variety of specially curated products and formats made in-house and/or sourced from micro-cultivators looking for a medical distribution outletAs a supplemental market to insured benefits channel Starseed Medicinal, Syndicate will offer clients sans insurance access a variety of brand favourites including... Read More...
Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer

Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer

TORONTO, Sept. 16, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce the appointment of James Afara as the Company’s Chief Operating Officer (COO). A results-driven leader with an exceptional trac... Read More...
Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program

Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program

TORONTO, Aug. 30, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce its medical subsidiary Starseed Medicinal (“Starseed”) has added four new union groups to its full-service, proprietary medical... Read More...
Entourage Health Reports Second Quarter 2022 Financial Results

Entourage Health Reports Second Quarter 2022 Financial Results

TORONTO, Aug. 29, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and six months ended June 30, 2022. The Company reported second quarter 2022 total revenue of $13.... Read More...
Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022

Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022

TORONTO, Aug. 11, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, August 29, 2... Read More...
Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada

Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada

Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent release of recommendations for easing access to over-the-counter CBD-products in pharmacies TORONTO, Aug. 04, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage... Read More...
Entourage Health Provides Update on Credit Facilities' Maturity Dates and Amends Outstanding Unsecured Convertible Debentures

Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures

TORONTO, July 29, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has satisfied certain conditions in connection with the recent amendments to its existing senior secured credit facility entered in... Read More...
Entourage Expands Medical Offerings with Launch of New Services and Products

Entourage Expands Medical Offerings with Launch of New Services and Products

Starseed signs with HelloMD’s telehealth network to support high volume of patient consultations Debuts customized patient treatment plans which could support pain management and opioid-displacement TORONTO, July 26, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and... Read More...
Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth

Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth

TORONTO, July 04, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce it has amended its existing senior secured credit facility entered into on March 29, 2019 (the “Senior Credit Facility”) betwee... Read More...
Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures

Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures

TORONTO, June 27, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central... Read More...
Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures

Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures

TORONTO, June 21, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to provide an update on the previously announced proposed amendments (the “Proposed Amendments”) to the trust indenture dated as of Septemb... Read More...
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures

Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures

TORONTO, June 20, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that holders (the “Debentureholders”) of the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the “Deben... Read More...
Entourage Announces Results of 2022 Annual General Meeting of Shareholders

Entourage Announces Results of 2022 Annual General Meeting of Shareholders

TORONTO, June 15, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general and special meeting of shareholders (“... Read More...
Entourage Health Extends its Senior Secured Credit Facility Maturity Date

Entourage Health Extends its Senior Secured Credit Facility Maturity Date

TORONTO, June 01, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019 (the “Credit Facility”). The... Read More...
Entourage Health Reports Record First Quarter 2022 Financial Results

Entourage Health Reports Record First Quarter 2022 Financial Results

Gross revenue* of $17.4 million, up 28% sequentially and 37% year over year Total revenue of $15.8 million in Q1, 2022 represents a 17% sequential increase over Q4 2021Gross Profit Before Fair Value Changes improved $5.5 million sequentially Adjusted EBITDA improved $1.0 million from Q4 2021, reflecting higher gross profit as Company real... Read More...
Entourage Health Announces Canadian Debut of The Boston Beer Company's New Cannabis-Infused Iced Tea Beverages ‘TeaPot'

Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’

TORONTO, May 24, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and The Boston Beer Company, Inc. (NYSE: SAM), (“BBC”) maker of iconic, high-quality brands such as Samuel Adams, Truly Hard Seltzer and Twisted Tea, ar... Read More...
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022

Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022

TORONTO, May 20, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday... Read More...
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures

Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures

TORONTO, May 13, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured c... Read More...
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th

Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th

TORONTO, May 10, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today that George Scorsis, CEO and Executive Chair, and Vaani Maharaj, Chief Financial Officer, are scheduled to prese... Read More...
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million

Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million

Net revenue increased to $42.2 million for the full year ended December 31, 2021 Preliminary unaudited Q1 2022 total revenue $17.4 million(1) representing 35% YOY growthUpsized credit facility with LiUNA Pension Fund further improves liquidity position TORONTO, May 09, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OT... Read More...
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients

Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients

TORONTO, May 04, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today it has entered into an agreement with Fire & Flower Holdings Corp. ("Fire & Flower") (TSX: FAF; OTCQX: F... Read More...
Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results

Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results

Company reaffirms previously announced full-year 2021 preliminary revenue with further improvements at $55.2 million(1) and preliminary gross margins of 7.0%(1) for the year TORONTO, May 03, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and di... Read More...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability

Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability

TORONTO, April 29, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “Credit Facility”) with an affi... Read More...
Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022

Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022

Company reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Results to be filed after-market May 2, 2022, with management hosting a call on following day TORONTO, April 22, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and... Read More...
Entourage Health Extends Senior Secured Credit Facility Maturity Date

Entourage Health Extends Senior Secured Credit Facility Maturity Date

TORONTO, March 30, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an additional amendment (the “Amendment”) to its senior secured credit facility entered into on M... Read More...
Entourage Health Launches ‘Joints for Justice' Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty

Entourage Health Launches ‘Joints for Justice’ Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty

TORONTO, March 25, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today that its Royal City Cannabis Co. (“Royal City") brand recently launched ‘RC Joints for Justice’, a ... Read More...
Entourage Health Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26

Entourage Health Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26

Ms. Maharaj to succeed Beth Carreon who is stepping down from CFO role effective May 4, 2022Company also reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Management to host financial results conference call on April 26, 2022 at 10 a.m. Eastern time TORONTO, March 24, 2022 -- Entourage Health Corp. (formerly WeedMD ... Read More...
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team

Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team

TORONTO, March 08, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands is pleased to unveil the refresh of its Color Cannabis (“Color”) adult-use brand with the launch of its new 2022 bra... Read More...
Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022  

Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022  

FYE 2021 revenues up 54% over prior year due to record sales and expanded market share(1)Conference call to review financial results to be held on April 1, 2022 at 10 a.m. Eastern time Company also provides a corporate update to confirm George Scorsis as permanent CEO TORONTO, Feb. 11, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.)... Read More...
Coming Soon.
IndexLast% Change
S&P 5004,288.05--
Euro STOXX 504,162.750.29%Negative
FTSE 1007,576.670.41%Negative
Nikkei 22531,759.880.31%Negative

Delayed data (1h)
IndexLast% Change
S&P 5004,288.05--
Euro STOXX 504,162.750.29%Negative
FTSE 1007,576.670.41%Negative
Nikkei 22531,759.880.31%Negative


Share this page